DR. PRAVEEN K. TAMIRISA, MD

BURLESON, TX

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 4 publications 1995 – 2001 NPI: 1679577597
Signal TransductionApoptosisCardiovascular DiseasesMyocardiumAdaptation, PhysiologicalEndothelium, VascularProteinsAorta, ThoracicVasoconstrictor AgentsEndothelinsReceptors, EndothelinPhenylephrineEndothelin Receptor AntagonistsAdrenergic alpha-AgonistsCalcium-Calmodulin-Dependent Protein Kinases

Practice Location

11803 SOUTH FWY STE 115
BURLESON, TX 76028-7028

Phone: (817) 293-8441

What does PRAVEEN TAMIRISA research?

Dr. Tamirisa studies how certain proteins and molecules in the body impact heart health and diseases. His work particularly examines endothelins, which can narrow blood vessels and contribute to heart issues, as well as a protein called RGS4 that influences how heart cells respond to stress. By targeting these elements, Dr. Tamirisa aims to uncover new treatments and strategies for managing cardiovascular diseases, including heart failure and high blood pressure, ultimately improving outcomes for patients suffering from these conditions.

Key findings

  • Targeting endothelins can lead to new drugs that effectively treat cardiovascular diseases.
  • Mice with increased levels of RGS4 showed significantly less heart enlargement under pressure overload, which could reduce mortality risk.
  • Adding RGS4 to heart cells blocked harmful signaling effects, suggesting it may protect against damage linked to heart disease.

Frequently asked questions

Does Dr. Tamirisa study heart disease?
Yes, Dr. Tamirisa specializes in researching various aspects of heart disease and potential treatments.
What treatments has Dr. Tamirisa researched?
He has researched treatments involving endothelins and RGS4 proteins, which may help manage cardiovascular conditions.
Is Dr. Tamirisa's work relevant to patients with high blood pressure?
Absolutely, his studies on endothelins are particularly relevant as they are linked to blood vessel constriction and high blood pressure.

Publications in plain English

Endothelin as a therapeutic target in the treatment of cardiovascular disease.

2001

Heart disease (Hagerstown, Md.)

Kaur S, Frishman WH, Singh I, Tamirisa P, Kumar A

Plain English
This study looked at endothelins, which are substances in the body that can narrow blood vessels and influence cell growth. Researchers found that targeting these substances with specific drugs shows promise in treating heart and blood vessel diseases. Understanding how to block endothelins could lead to new and effective ways to improve cardiovascular health. Who this helps: Patients with cardiovascular disease.

PubMed

RGS4 inhibits G-protein signaling in cardiomyocytes.

1999

Circulation

Tamirisa P, Blumer KJ, Muslin AJ

Plain English
This study looked at how a protein called RGS4 can stop certain signaling processes in heart cells that are linked to heart problems, like enlargement or failure. Researchers found that when they added RGS4 to heart cells, the harmful effects caused by signals from substances like phenylephrine and endothelin-1 were blocked, reducing cell growth and changes in the cell structure. These findings are important because they suggest that boosting RGS4 levels could help protect heart cells from damage caused by excessive signaling, potentially offering a new way to address heart disease. Who this helps: This helps patients with heart problems by providing a possible new treatment approach.

PubMed

RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload.

1999

The Journal of clinical investigation

Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M +3 more

Plain English
This study looked at a protein called RGS4 and how it affects heart function under stress from pressure overload. Researchers found that mice with extra RGS4 developed much less heart enlargement when faced with pressure than normal mice and had a higher risk of dying after the heart was stressed. This matters because understanding the role of RGS4 helps us identify important factors in heart conditions, potentially leading to better treatments for heart disease. Who this helps: This helps patients with heart conditions and their doctors.

PubMed

Endothelin and endothelin antagonism: roles in cardiovascular health and disease.

1995

American heart journal

Tamirisa P, Frishman WH, Kumar A

Plain English
This research focuses on a powerful molecule called endothelin, which can constrict blood vessels and is linked to various heart and blood vessel issues, including heart disease and high blood pressure. The study found that endothelin affects important processes in the body and that certain drugs can block its effects, potentially leading to new treatments. Understanding endothelin's role is crucial because it could help develop better ways to manage cardiovascular diseases. Who this helps: Patients with heart and vascular conditions.

PubMed

Frequent Co-Authors

W H Frishman A Kumar K J Blumer A J Muslin S Kaur I Singh J H Rogers A Kovacs C Weinheimer M Courtois

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.